Clover Health Investments (CLOV) vs Elevance Health (ELV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Clover Health Investments (CLOV) has outperformed Elevance Health (ELV) over the past year, gaining 68.9% versus a gain of 13.9%. Over five years, ELV leads with a +3.6% price change compared with -42.4% for CLOV. Elevance Health is the larger company by market cap ($87.68 billion vs $2.42 billion), about 36.2 times the size.
On valuation, Elevance Health trades at a lower forward P/E (13.7x vs 30.4x for Clover Health Investments). Elevance Health pays a dividend yielding 1.70%, while Clover Health Investments does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLOV | ELV |
|---|---|---|
| Share price | $4.56 | $404.31 |
| Market cap | $2.42B | $87.68B |
| 1-day change | -0.87% | +1.05% |
| YTD return | +94.04% | +16.12% |
| 1-year return | +68.89% | +13.87% |
| 5-year return | -42.35% | +3.57% |
| P/E ratio (TTM) | — | 17.90 |
| Forward P/E | 30.40 | 13.69 |
| EPS (TTM) | $-0.05 | $22.59 |
| Dividend yield | 0.00% | 1.70% |
| Annual dividend | $0.00 | $6.86 |
| Revenue (latest FY) | — | $199.13B |
| Revenue growth (YoY) | — | +12.49% |
| Net income (latest FY) | — | $5.66B |
| Gross margin | — | 89.36% |
| Operating margin | — | 3.62% |
| Net margin | — | 2.84% |
| 52-week high | $5.59 | $436.24 |
| 52-week low | $1.58 | $274.84 |
| Distance from 52-week high | -18.43% | -7.32% |
| Analyst consensus | none | buy |
| Avg. price target upside | +17.98% | +11.67% |
| Average volume | 4.27M | 1.20M |
| Shares outstanding | 435.44M | 216.87M |
| Employees | 724 | 96,129 |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Plans | Healthcare Plans |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Elevance Health is about 36.2 times larger than Clover Health Investments by market value ($87.68B vs $2.42B).
- CLOV has outperformed ELV by 55.0 percentage points over the past year.
- Elevance Health offers a meaningfully higher dividend yield (1.70% vs 0.00%).
About Clover Health Investments
CLOV stock →Clover Health Investments, Corp. provides medicare advantage plans in the United States.
Healthcare · Healthcare Plans · 724 employees
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Healthcare · Healthcare Plans · 96,129 employees
CLOV vs ELV FAQ
Which is bigger, Clover Health Investments or Elevance Health?
Elevance Health (ELV) is larger, with a market capitalization of $87.68B compared with $2.42B for Clover Health Investments (CLOV).
Which stock has performed better over the past year, CLOV or ELV?
CLOV returned +68.89% over the past 12 months, compared with +13.87% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Clover Health Investments or Elevance Health?
Elevance Health pays a dividend yielding 1.70%, while Clover Health Investments does not currently pay a regular dividend.
Are Clover Health Investments and Elevance Health in the same industry?
Yes. Both are classified in the Healthcare Plans industry within the Healthcare sector.